Search

1153113
1153120
1153255
1153257
The IDM - a transfaculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases & molecular medicine
Cell Imaging Microscope
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific & clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries & 24 countries beyond.
IDM capacity building
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research & health sciences human capital development.
Clinical research
Clinical research relevant to the needs of Africa's people
The IDM infuences health policy and practice by translating our scientific discoveries and applying them in the various communities; community relationships and trust are critical.

   IDM overview                        YouTube

University accredited research institute
Tackling diseases of importance in Africa
Developing people
Impacting health policy and practice
 


News

Thursday, 22 November 2018
Prednisone reduces risk of TB-IRIS during antiretroviral treatment

Researchers from UCT and the Institute of Tropical Medicine (Belgium) have shown that a four-week course of moderate dose prednisone reduced the risk of tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) by 30% in HIV-positive patients. This is the first trial to show that TB-IRIS can be prevented in these patients and represents an important contribution to the body of knowledge on management of HIV-TB co-infection.

TB-IRIS is a serious risk in people living with HIV, resulting in hospitalisation of a quarter of people who experience it. The syndrome occurs in 18% of patients with HIV-associated TB initiating antiretroviral therapy.

Publication Date:
Thu, 15 Nov 2018 - 09:00
Paediatric cardiologist wins prestigious award

Paediatric cardiologist Associate Professor Liesl Zühlke has recently won the prestigious SA Medical Research Council/ UK Department of International Development(MRC/DFID) African Research Leader Award. The award, valued at £750 000 (R14.565 million) over 5 years, will assist Prof Zühlke in continuing her research of children with heart disease in Africa,  in partnership with Prof Bernard Kheavney (UK) as well as local partners Prof Mark Engel, Dr Gasnat Shaboodien, Prof Raj Ramasar, Prof Mpiko Ntsekhe, Dr Blanche Cupido and Prof Ntobeko Ntusi.

Publication Date:
Fri, 26 Oct 2018 - 13:30
Desmond Tutu Award for HIV Prevention Research and Human Rights to be presented to Linda-Gail Bekker at HIV Research for Prevention (HIVR4P) 2018

The co-chairs of HIV Research for Prevention (HIVR4P 2018), the world’s only scientific meeting dedicated exclusively to biomedical HIV prevention, have announced that the 2018 Desmond Tutu Award for HIV Prevention Research and Human Rights will be presented to HIV researcher, physician and community advocate Linda-Gail Bekker of Cape Town, South Africa. The presentation will take place at the Opening Plenary of this year’s HIVR4P conference, Monday 22 October in Madrid, Spain.

Publication Date:
Mon, 22 Oct 2018 - 09:45
Wellcome Trust Seed Fund Award for Neuroscience

Congratulations to Dr. Joseph Raimondo and his team for receiving the Wellcome Trust Seed Award. Seed Awards help researchers develop novel ideas that will go on to form part of larger grant applications to Wellcome or elsewhere.

Publication Date:
Fri, 12 Oct 2018 - 08:45

Pages